AMPK-mediated regulation of transcription in skeletal muscle

Clinical Science

Volumn 118, Issue 8, 2010, Pages 507-518

  McGee, Sean L ^a   Hargreaves, Mark ^b  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AMP activated protein kinase (AMPK); Angiogenesis; Oxidative capacity; Skeletal muscle; Transcription

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANGIOGENESIS; BIOGENESIS; CARDIOVASCULAR DISEASE; ENERGY BALANCE; ENZYME SUBSTRATE; EXERCISE TOLERANCE; GENE EXPRESSION; HEALTH STATUS; HUMAN; METABOLIC SYNDROME X; MITOCHONDRION; MUSCLE ATROPHY; MUSCLE METABOLISM; OXIDATION; PHENOTYPE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

AMP-ACTIVATED PROTEIN KINASES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 76849083600     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090533     Document Type: Review

References (101)

1. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E. et al. (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273
2. Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R. et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 100, 8466-8471
3. Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. and Shulman, G. I. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J Med. 350, 664-671
4. Wisløff, U., Najjar, S. M., Ellingsen, O., Haram, P. M., Swoap, S., Al-Share, Q., Fernström, M., Rezaei, K., Lee, S. J., Koch, L. G. and Britton, S. L. (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307, 334-335
5. Mishra, S. K. and Misra, V. (2003) Muscle sarcopenia: an overview. Acta Myol. 22, 43-47 6 Balasubramanian, V. P. and Varkey, B. (2006) Chronic obstructive pulmonary disease: effects beyond the lungs. Curr. Opin. Pulm. Med. 12, 106-112
6. Bernardi, P. and Bonaldo, P. (2008) Dysfunction of mitochondria and sarcoplasmic reticulum in the pathogenesis of collagen VI muscular dystrophies. Ann. N.Y. Acad. Sci. 1147, 303-311
7. Joseph, A. M., Pilegaard, H., Litvintsev, A., Leick, L. and Hood, D. A. (2006) Control of gene expression and mitochondrial biogenesis in the muscular adaptation to endurance exercise. Essays Biochem. 42, 13-29
8. Civitarese, A. E., Carling, S., Heilbronn, L. K., Hulver, M. H., Ukropcova, B., Deutsch, W. A., Smith, S. R. and Ravussin, E. (2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 4, e76
9. Hardie, D. G., Hawley, S. A. and Scott, J. W. (2006) AMP-activated protein kinase: development of the energy sensor concept. J. Physiol. 574, 7-15
10. Steinberg, G. R. and Kemp, B. E. (2009) AMPK in health and disease. Physiol. Rev. 89, 1025-1078
11. Wojtaszewski, J. P., Birk, J. B., Frosig, C., Holten, M., Pilegaard, H. and Dela, F. (2005) 5′ AMPK activated protein kinase in human skeletal muscle: effects of strength training and type 2 diabetes. J. Physiol. 564, 563-573
12. Polekhina, G., Gupta, A., Michell, B. J., van Denderen. B., Murthy, S., Feil, S.C., Jennings, I.G., Campbell, D. J., Witters, L.A, Parker M.W. et al. (2003) AMPKβ subunit targets metabolic stress sensing to glycogen. Curr. Biol. 13, 867-871
13. Scott, J. W., Ross, F. A., Liu, J. K. and Hardie, D. G. (2007) Regulation of AMP-activated protein kinase by a pseudosubstrate sequence on the γ subunit. EMBO J. 26, 806-815
14. Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Makela, T. P., Alessi, D. R. and Hardie, D. G. (2003) Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28
15. Hong, S. P., Leiper, F. C., Woods, A., Carling, D. and Carlson, M. (2003) Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. U.S.A. 100, 8839-8843
16. Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M. and Carling, D. (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004-2008
17. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G. and Hardie D.G. (2005) Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19
18. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280, 29060-29066
19. Momcilovic, M., Hong, S. P. and Carlson, M. (2006) Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 281, 25336-25343
20. 2+/ calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33
21. Steinberg, G. R., Michell, B. J., van Denderen, B. J., Watt, M. J., Carey, A. L., Fam, B. C., Andrikopoulos, S., Proietto, J., Gorgun, C. Z., Carling, D. et al. (2006) Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 4, 465-474
22. Chen, Z. P., Stephens, T. J., Murthy, S., Canny, B. J., Hargreaves, M., Witters, L. A., Kemp, B. E. and McConell, G. K. (2003) Effect of exercise intensity on skeletal muscle AMPK signalling in humans. Diabetes 52, 2205-2212
23. Dreyer, H. C., Fujita, S., Cadenas, J. G., Chinkes, D. L., Volpi, E. and Rasmussen, B. B. (2006) Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J. Physiol. 576, 613-624
24. Birk, J. B. and Wojtaszewski, J. P. (2006) Predominant α2/β2 /γ3 AMPK activation during exercise in human skeletal muscle. J. Physiol. 577, 1021-1032
25. Tamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295
26. Minokoshi, Y., Kim, Y. B., Peroni, O. D., Fryer, L. G., Müller, C., Carling, D. and Kahn, B. B. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343
27. Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E. et al. (2006) Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55, 2688-2697
28. q-coupled receptors. Biochem. Biophys. Res. Commun. 276, 16-22
29. Kristensen, J. M., Johnsen, A. B., Birk, J. B., Nielsen, J. N., Jensen, B. R., Hellsten, Y., Richter, E. A. and Wojtaszewski, J. F. (2007) Absence of humoral mediated 5′ AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J. Physiol. 585, 897-909
30. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174
31. Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S. et al. (2002) Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081
32. Corton, J., Gillespie, J., Hawley, S. and Hardie, D.G. (1995) 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 229, 558-565
33. Boon, H., Bosselaar, M., Praet, S. F., Blaak, E. E., Saris, W. H., Wagenmakers, A. J., McGee, S. L., Tack, C. J., Smits, P., Hargreaves, M. and van Loon, L. J. (2008) Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Diabetologia 51, 1893-1900
34. Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R. et al. (2006) Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403-416
35. Scott, J. W., van Denderen, B. J., Jorgensen, S. B., Honeyman, J. E., Steinberg, G. R., Oakhill, J. S., Iseli, T. J., Koay, A., Gooley, P. R., Stapleton, D. and Kemp, B. E. (2008) Thienopyridone drugs are selective activators of AMP-activated protein kinase β1-containing complexes. Chem. Biol. 15, 1220-1230
36. Göransson, O., McBride, A., Hawley, S. A., Ross, F. A., Shpiro, N., Foretz, M., Viollet, B., Hardie, D. G. and Sakamoto, K. (2007) Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J. Biol. Chem. 282, 32549-32560
37. a Treebak, J. T., Birk, J. B., Hansen, B. F., Olsen, G. S. and Wojtaszewski, J. F. (2009) A-769662 activates AMPKβ1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 297, C1041-C1052
38. Steinberg, G. R., Smith, A. C., van Denderen, B. J. W., Chen, Z. P., Murthy, S., Campbell, D. J., Heigenhauser, G. J. F, Dyck, D. J. and Kemp, B. E. (2004) AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin. Endocinol. Metab. 89, 4575-4580
39. Munday, M. R., Carling, D. and Hardie, D. G. (1988) Negative interactions between phosphorylation of acetyl-CoA carboxylase by the cyclic AMP-dependent and AMP-activated protein kinases. FEBS Lett. 223, 217-222
40. Merrill, G. F., Kurth, E. J., Hardie, D. G. and Winder, W. W. (1997) AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273, E1107-E1112
41. Chavez, J. A., Roach, W. G., Keller, S. R., Lane, W. S. and Lienhard, G. E. (2008) Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J. Biol. Chem. 283, 9187-9195
42. Marsin, A. S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., Van den Berghe, G., Carling, D. and Hue, L. (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247-1255
43. Chen, Z., Chen Peng, I., Sun, W., Su, M. I., Hsu, P. H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M. D. and Shyy, J. Y. J. (2009) AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase ser633. Circ. Res. 104, 496-505
44. Zwetsloot, K. A., Westerkamp, L. M., Holmes, B. F. and Gavin, T. P. (2008) AMPK regulates basal skeletal muscle capillarization and VEGF expression, but is not necessary for the angiogenic response to exercise. J. Physiol. 586, 6021-6035
45. Zheng, D., MacLean, P. S., Pohnert, S. C., Knight, J. B., Olson, A. L., Winder, W. W. and Dohm, G. L. (2001) Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J. Appl. Physiol. 91, 1073-1083
46. Stoppani, J., Hildebrandt, A. L., Sakamoto, K., Cameron-Smith, D., Goodyear, L. J. and Neufer, P. D. (2002) AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283, E1239-E1248
47. Chabowski, A., Momken, I., Coort, S. L., Calles-Escandon, J., Tandon, N. N., Glatz, J. F., Luiken, J. J. and Bonen, A. (2006) Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol. Cell. Biochem. 288, 201-212
48. Barnes, B. R., Long, Y. C., Steiler, T. L., Leng, Y., Galuska, D., Wojtaszewski, J. F., Andersson, L. and Zierath, J. R. (2005) Changes in exercise-induced gene expression in 5′-AMP-activated protein kinase γ3-null and γ3 R225Q transgenic mice. Diabetes 54, 3484-3489
49. Jorgensen, S. B.,Wojtaszewski, J. F., Viollet, B., Andreelli, F., Birk, J. B., Hellsten, Y., Schjerling, P., Vaulont, S., Neufer, P. D., Richter, E. A. and Pilegaard, H. (2005) Effects of α-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J. 19, 1146-1148
50. Jorgensen, S. B., Treebak, J. T., Viollet, B., Schjerling, P., Vaulont, S., Wojtaszewski, J. F. and Richter, E. A. (2007) Role of AMPKα2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am. J. Physiol. Endocrinol. Metab. 292, E331-E339
51. Garcia-Roves, P. M., Osler, M. E., Holmström, M. H. and Zierath, J. R. (2008) Gain-of-function R225Q mutation in AMP-activated protein kinase γ3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J. Biol. Chem. 283, 35724-35734
52. Handschin, C. and Spiegelman, B. M. (2006) Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 27, 728-735
53. Lin, J., Wu, H., Tarr, P. T., Zhang, C. Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N. et al. (2002) Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibres. Nature 418, 797-801
54. Kang, D., Kim, S. H. and Hamasaki, N. (2007) Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 7, 39-44
55. Barnes, B. R., Marklund, S., Steiler, T. L., Walter, M., Hjalm, G., Amerger, V., Mahlapuu, M., Leng, Y., Johansson, C., Galuska, D. et al. (2004) The 5′-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem. 279, 38441-38447
56. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H. et al. (2008) AMPK and PPARδ agonists are exercise mimetics. Cell 134, 405-415
57. Putman, C. T., Kiricsi, M., Pearcey, J., MacLean, I. M., Bamford, J. A., Murdoch, G. K., Dixon, W. T. and Pette, D. (2003) AMPK activation increases uncoupling protein-3 expression and mitochondrial enzyme activities in rat muscle without fibre type transitions. J. Physiol. 551, 169-178
58. Röckl, K. S., Hirshman, M. F., Brandauer, J., Fujii, N., Witters, L. A. and Goodyear, L. J. (2007) Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 56, 2062-2069
59. Holmes, B. F., Lang, D. B., Birnbaum, M. J., Mu, J. and Dohm, G. L. (2004) AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 287, E739-E743
60. Lee-Young, R. S., Griffee, S. R., Lynes, S. E., Bracy, D. P., Ayala, J. E., McGuinness, O. P. and Wasserman, D. H. (2009) Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J. Biol. Chem. 284, 23925-23934
61. Fujii, N., Seifert, M. M., Kane, E. M., Peter, L. E., Ho, R. C., Winstead, S., Hirshman, M. F. and Goodyear, L. J. (2007) Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle: insight from analysis of a transgenic mouse model. Diabetes Res. Clin. Pract. 77, (Suppl. 1), S92-S98
62. Maarbjerg, S. J., Jorgensen, S. B., Rose, A. J., Jeppesen, J., Jensen, T. E., Treebak, J. T., Birk, J. B., Schjerling, P., Wojtaszewski, J. F. and Richter, E. A. (2009) Genetic impairment of α2-AMPK signaling does not reduce muscle glucose uptake during treadmill exercise in mice. Am. J. Physiol. Endocrinol. Metab. 297, E924-E934
63. Fujii, N., Ho, R. C., Manabe, Y., Jessen, N., Toyoda, T., Holland, W. L., Summers, S. A., Hirshman, M. F. and Goodyear, L. J. (2008) Ablation of AMP-activated protein kinase α2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 57, 2958-2966
64. Jørgensen, S. B., O'Neill, H. M., Hewitt, K., Kemp, B. E. and Steinberg, G. R. (2009) Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 52, 2395-2404
65. Dzamko, N., Schertzer, J. D., Ryall, J. G., Steel, R., Macaulay, S. L., Wee, S., Chen, Z. P., Michell, B. J., Oakhill, J. S., Watt, M. J. et al. (2008) AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J. Physiol. 586, 5819-5831
66. Murgia, M., Jensen, T. E., Cusinato, M., Garcia, M., Richter, E. A. and Schiaffino, S. (2009) Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle. J. Physiol. 587, 4319-4327
67. Vogelstein, B., Lane, D. and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
68. Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F. and Hwang, P. M. (2006) p53 regulates mitochondrial respiration. Science 312, 1650-1653
69. Saleem, A., Adhihetty, P. J. and Hood, D. A. (2009) Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle. Physiol. Genomics 37, 58-66
70. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J. and Thompson, C. B. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283-293
71. Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M. and Esumi, H. (2001) Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 287, 562-567
72. Haberland, M., Montgomery, R. L. and Olson, E. N. (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42
73. Lemercier, C., Verdel, A., Galloo, B., Curtet, S., Brocard, M. P. and Khochbin, S. (2000) mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275, 15594-15599
74. Czubryt, M. P., McAnally, J., Fishman, G. I. and Olson, E. N. (2003) Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. U.S.A. 100, 1711-1716
75. McGee, S. L., van Denderen, B. J., Howlett, K. F., Mollica, J., Schertzer, J. D., Kemp, B. E. and Hargreaves, M. (2008) AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57, 860-867
76. McKinsey, T., Zhang, C. and Olson, E. N. (2000) Signal-dependent nuclear export of a histone deactylase regulates muscle differentiation. Nature 408, 106-111
77. Urbich, C., Rössig, L., Kaluza, D., Potente, M., Boeckel, J. N., Knau, A., Diehl, F., Geng, J. G., Hofmann, W. K., Zeiher, A. M. and Dimmeler, S. (2009) HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells. Blood 113, 5669-5679
78. Chang, S., Young, B. D., Li, S., Qi, X., Richardson, J. A. and Olson, E. N. (2006) Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126, 321-334
79. Chang, S., Bezprozvannaya, S., Li, S. and Olson, E. N. (2005) An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 102, 8120-8125
80. Choi, C. S., Befroy, D. E., Codella, R., Kim, S., Reznick, R. M., Hwang, Y. J., Liu, Z. X., Lee, H. Y., Distefano, A., Samuel, V. T. et al. (2008) Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc. Natl. Acad. Sci. U.S.A. 105, 19926-19931
81. Benton, C. R., Nickerson, J. G., Lally, J., Han, X. X., Holloway, G. P., Glatz, J. F., Luiken, J. J., Graham, T. E., Heikkila, J. J. and Bonen, A. (2008) Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J. Biol. Chem. 283, 4228-4240
82. Jäger, S., Handschin, C., St-Pierre, J. and Spiegelman, B. M. (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U.S.A. 104, 12017-12022
83. Knutti, D., Kressler, D. and Kralli, A. (2001) Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc. Natl. Acad. Sci. U.S.A. 98, 9713-9718
84. Handschin, C., Rhee, J., Lin, J., Tarr, P. T. ad Spiegelman and B.M. (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle. Proc. Natl. Acad. Sci. U.S.A. 100, 7111-7116
85. Leick, L., Wojtaszewski, J. F., Johansen, S. T., Kiilerich, K., Comes, G., Hellsten, Y., Hidalgo, J. and Pilegaard, H. (2008) PGC-1α is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 294, E463-E474
86. Yoshioka, T., Inagaki, K., Noguchi, T., Sakai, M., Ogawa, W., Hosooka, T., Iguchi, H., Watanabe, E., Matsuki, Y., Hiramatsu, R. and Kasuga, M. (2009) Identification and characterization of an alternative promoter of the human PGC-1α gene. Biochem. Biophys. Res. Commun. 381, 537-543
87. Thomson, D. M., Herway, S. T., Fillmore, N., Kim, H., Brown, J. D., Barrow, J. R. and Winder, W.W. (2008) AMP-activated protein kinase phosphorylates transcription factors of the CREB family. J. Appl. Physiol. 104, 429-438
88. Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P. et al. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183
89. Berdeaux, R., Goebel, N., Banaszynski, L., Takemori, H., Wandless, T., Shelton, G. D. and Montminy, M. (2007) SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat. Med. 13, 597-603
90. Thomson, D. M., Porter, B. B., Tall, J. H., Kim, H. J., Barrow, J. R. and Winder, W. W. (2007) Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice. Am. J. Physiol. Endocrinol. Metab. 292, E196-E202
91. Koo, S. H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P. et al. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111
92. Wu, Z., Huang, X., Feng, Y., Handschin, C., Feng, Y., Gullicksen, P. S., Bare, O., Labow, M., Spiegelman, B. M. and Stevenson, S. C. (2006) Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1α transcription and mitochondrial biogenesis in muscle cells. Proc. Natl. Acad. Sci. U.S.A. 103, 14379-14384
93. Greer, E. L., Oskoui, P. R., Banko, M. R., Maniar, J. M., Gygi, M. P., Gygi, S. P. and Brunet, A. (2007) The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282, 30107-30119
94. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015
95. Kamei, Y., Miura, S., Suzuki, M., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Hata, T., Matsuda, J., Aburatani, H. et al. (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279, 41114-41123
96. Barthel, A., Schmoll, D., Kruger, K. D., Roth, R. A. and Joost, H. G. (2002) Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 143, 3183-3186
97. Bergeron, R., Ren, J. M., Cadman, K. S., Moore, I. K., Perret, P., Pypaert, M., Young, L. H., Semenkovich, C. F. and Shulman, G. I. (2001) Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 281, E1340-E1346
98. Oshel, K., Knight, J., Cao, K., Thai, M. and Olson, A. L. (2000) Identification of a 30-base pair regulatory element and novel DNA binding protein that regulates the human GLUT4 promoter in transgenic mice. J. Biol. Chem. 275, 23666-23673
99. Holmes, B. F., Sparling, D. P., Olson, A. L., Winder, W. W. and Dohm, G. L. (2005) Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am. J. Physiol. Endocrinol. Metab. 289, E1071-E1076
100. + metabolism and SIRT1 activity. Nature 458, 1056-1060
101. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L. and Gu, W. (2001) Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107, 137-148